MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
85.62%
Quick Ratio
66.11%
Cash Ratio
22.46%
Debt to Asset Ratio
112.03%
Unit: Million (M) dollars
Assets Breakdown
    • Deferred tax assets
    • Accounts receivable, net of allo...
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Accrued rebates and product retu...
    • Long-term debt, less current por...
    • Accumulated deficit
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
175 195 445 510
Short-term investments
NaN 0 0 0
Accounts receivable, net of allowances of 3 (2026) and 4 (2025)
273 253 259 240
Inventories
152 153 155 149
Prepaid expenses
15 34 30 28
Current tax receivable
12 2 13 3
Other current assets
40 16 19 20
Total current assets
667 652 922 951
Long-term investments
27 28 28 27
Property, plant and equipment, net
157 144 124 117
Operating lease right of use assets, net
22 26 30 35
Goodwill and other intangible assets, net
2 2 NaN 7
Deferred tax assets
296 323 285 270
Other noncurrent assets
26 27 27 44
Total assets
1,197 1,201 1,416 1,452
Accrued rebates and product returns
551 582 613 709
Accounts payable and accrued expenses
178 250 215 196
Accrued litigation settlement expenses, current
14 42 106 105
Current portion of long-term debt
0 29 18 18
Operating lease liabilities, current
9 10 10 11
Income taxes payable
26 2 4 17
Other current liabilities
NaN 0 0 0
Total current liabilities
779 914 965 1,056
Long-term debt, less current portion
486 290 304 308
Accrued litigation settlement expenses, noncurrent
41 52 300 299
Operating lease liabilities, noncurrent
14 22 24 29
Other noncurrent liabilities
21 21 30 18
Total liabilities
1,341 1,300 1,623 1,709
Common stock, par value 0.50 per share issued shares 125 (2025) and 125 (2024)
NaN 62 62 62
Additional paid-in capital
165 112 109 101
Share repurchase commitment
NaN 0 0 0
Accumulated other comprehensive loss
-29 -30 -32 -33
Accumulated deficit
-280 -243 -346 -388
Total stockholders' deficit
-144 -98 -207 -257
Total liabilities and stockholders' deficit
1,197 1,201 1,416 1,452
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Accounts receivable, netof allowances of 3...$273M (12.35%↑ Y/Y)Cash and cashequivalents$175M (-52.96%↓ Y/Y)Inventories$152M (-6.75%↓ Y/Y)Other current assets$40M (100.00%↑ Y/Y)Prepaid expenses$15M (-73.21%↓ Y/Y)Current tax receivable$12M (-58.62%↓ Y/Y)Total current assets$667M (-24.46%↓ Y/Y)Deferred tax assets$296M (6.09%↑ Y/Y)Property, plant andequipment, net$157M (50.96%↑ Y/Y)Long-term investments$27M (0.00%↑ Y/Y)Other noncurrentassets$26M (-33.33%↓ Y/Y)Operating lease right ofuse assets, net$22M (-40.54%↓ Y/Y)Goodwill and otherintangible assets, net$2M (-71.43%↓ Y/Y)Total assets$1,197M (-12.95%↓ Y/Y)Accumulated deficit-$280M (31.03%↑ Y/Y)Accumulated othercomprehensive loss-$29M (17.14%↑ Y/Y)Total liabilities andstockholders' deficit$1,197M (-12.95%↓ Y/Y)Total stockholders'deficit-$144M (49.47%↑ Y/Y)Additional paid-in capital$165M (77.42%↑ Y/Y)Total liabilities$1,341M (-19.22%↓ Y/Y)Total currentliabilities$779M (-22.49%↓ Y/Y)Long-term debt, lesscurrent portion$486M (56.27%↑ Y/Y)Accrued litigationsettlement expenses,...$41M (-86.20%↓ Y/Y)Other noncurrentliabilities$21M (23.53%↑ Y/Y)Operating leaseliabilities, noncurrent$14M (-53.33%↓ Y/Y)Accrued rebates andproduct returns$551M (-18.37%↓ Y/Y)Accounts payable andaccrued expenses$178M (-2.73%↓ Y/Y)Income taxes payable$26M (116.67%↑ Y/Y)Accrued litigationsettlement expenses,...$14M (-86.67%↓ Y/Y)Operating leaseliabilities, current$9M (-18.18%↓ Y/Y)

indivior-logo-svg

Indivior Pharmaceuticals, Inc. (INDV)

indivior-logo-svg

Indivior Pharmaceuticals, Inc. (INDV)